Senate Seeks Details Of Antidepressant Suicide Data Evaluation By Columbia University
This article was originally published in The Pink Sheet Daily
Executive Summary
Sen. Charles Grassley is requesting information on the "rationale" for a non-FDA review of the data. The request is part of an ongoing investigation of the agency's handling of suicide-related events in pediatric antidepressant data.